BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31218580)

  • 1. Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia: a systematic review.
    Ahumada-Canale A; Quirland C; Martinez-Mardones FJ; Plaza-Plaza JC; Benrimoj S; Garcia-Cardenas V
    Eur J Health Econ; 2019 Sep; 20(7):1103-1116. PubMed ID: 31218580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.
    Martínez-Mardones F; Fernandez-Llimos F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; S Tonin F; Garcia-Cardenas V
    J Am Heart Assoc; 2019 Nov; 8(22):e013627. PubMed ID: 31711390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.
    Wang Y; Yeo QQ; Ko Y
    Diabet Med; 2016 Apr; 33(4):421-7. PubMed ID: 26433008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of economic evaluations of pharmacist services.
    Price E; Shirtcliffe A; Fisher T; Chadwick M; Marra CA
    Int J Pharm Pract; 2023 Sep; 31(5):459-471. PubMed ID: 37543960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes.
    Geng J; Yu H; Mao Y; Zhang P; Chen Y
    Pharmacoeconomics; 2015 Jun; 33(6):581-97. PubMed ID: 25736235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.
    Romano S; Figueira D; Teixeira I; Perelman J
    Pharmacoeconomics; 2022 Mar; 40(3):269-295. PubMed ID: 34913143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.
    Abdulrhim S; Sankaralingam S; Ibrahim MIM; Awaisu A
    Prim Care Diabetes; 2020 Oct; 14(5):393-400. PubMed ID: 31926868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A systematic review on population-based indicators of the quality of care in formal and informal provider networks and their application in health economic evaluations].
    Seibert K; Stiefler S; Domhoff D; Wolf-Ostermann K; Peschke D
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():7-23. PubMed ID: 31327735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist-led medication review in community settings: An overview of systematic reviews.
    Jokanovic N; Tan EC; Sudhakaran S; Kirkpatrick CM; Dooley MJ; Ryan-Atwood TE; Bell JS
    Res Social Adm Pharm; 2017; 13(4):661-685. PubMed ID: 27665364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BC Clinical impact of medication reviews with follow-up in cardiovascular older patients in primary care: A cluster-randomized controlled trial.
    Martínez-Mardones F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; Garcia-Cardenas V
    Br J Clin Pharmacol; 2023 Jul; 89(7):2131-2143. PubMed ID: 36735853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Evaluation of Exercise-Based Fall Prevention Programs for People with Parkinson's Disease: A Systematic Review.
    Winser SJ; Paul LF; Magnus LKL; Yan S; Shenug TP; Sing YM; Cheing G
    J Altern Complement Med; 2019 Dec; 25(12):1225-1237. PubMed ID: 31556689
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Telehealth Interventions on Medication Adherence for Patients With Type 2 Diabetes, Hypertension, and/or Dyslipidemia: A Systematic Review.
    Bingham JM; Black M; Anderson EJ; Li Y; Toselli N; Fox S; Martin JR; Axon DR; Silva-Almodóvar A
    Ann Pharmacother; 2021 May; 55(5):637-649. PubMed ID: 32815400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.